Galapagos NV
(NASDAQ : GLPG)

( )
GLPG PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.04%202.891.3%$439.73m
BIIBBiogen Inc.
1.14%225.761.3%$382.28m
GILDGilead Sciences, Inc.
0.81%64.510.9%$362.26m
CELGCelgene Corporation
-0.18%100.391.3%$352.37m
ILMNIllumina, Inc.
2.56%310.313.5%$266.69m
REGNRegeneron Pharmaceuticals, Inc.
1.55%305.442.6%$219.74m
EXASExact Sciences Corporation
2.54%94.8524.1%$199.38m
ALXNAlexion Pharmaceuticals, Inc.
2.11%101.342.0%$181.06m
VRTXVertex Pharmaceuticals Incorporated
0.68%173.591.9%$178.83m
AAgilent Technologies, Inc.
-0.16%75.181.6%$153.77m
SRPTSarepta Therapeutics, Inc.
2.66%85.7014.6%$141.72m
ALDRAlder Biopharmaceuticals, Inc.
0.27%18.9210.2%$132.33m
BMRNBioMarin Pharmaceutical Inc.
-0.18%67.244.3%$95.95m
ACADACADIA Pharmaceuticals Inc.
-2.57%39.4813.4%$89.57m
SGENSeattle Genetics, Inc.
-0.22%82.426.2%$84.75m

Company Profile

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research and Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.